UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2023
Commission File Number: 001-39591
iHuman Inc.
(Registrant’s Name)
Floor 8, Building B,
No. 1 Wangjing East Road,
Chaoyang District, Beijing 100102
People’s Republic of China
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
iHuman Inc. |
| |
|
| |
|
|
|
| |
By |
: |
/s/ Vivien Weiwei Wang |
| |
Name |
: |
Vivien Weiwei Wang |
| |
Title |
: |
Director and Chief Financial Officer |
Date:
December 28, 2023
Exhibit 99.1
iHuman
Inc. Announces Third Quarter 2023 Unaudited Financial Results
BEIJING,
China, December 28, 2023 -- iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider
of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended
September 30, 2023.
Third Quarter 2023 Highlights
| ● | Revenues were RMB261.5 million (US$35.8 million), compared with RMB251.5 million in the same period last
year. |
| ● | Gross profit was RMB186.6 million (US$25.6 million), compared with RMB177.1 million in the same period
last year. |
| ● | Operating income was RMB40.4 million (US$5.5 million), compared with RMB38.5 million in the same period
last year. |
| ● | Adjusted operating income1
was RMB42.9 million (US$5.9 million), compared with RMB42.5 million in the same period last year. |
| ● | Net income was RMB51.9 million (US$7.1 million), compared with RMB39.5 million in the same period last
year. |
| ● | Adjusted net income1 was RMB54.4 million (US$7.5 million), compared with RMB43.5 million in
the same period last year. |
| ● | Average total MAUs2
reached a record-high of 25.36 million, a year-over-year increase of 22.9%. |
Dr. Peng
Dai, Director and Chief Executive Officer of iHuman, commented, “We are excited to announce another strong quarter of results with
average total MAUs increasing an impressive 22.9% year-over-year to reach another record-high of 25.36 million, which I believe
reflects our unwavering commitment to delivering exceptional experiences and value to our users.”
“During
the quarter, we focused squarely on strengthening our product portfolio in both domestic and international markets. Domestically, we further
refined our industry-leading offerings with improvements to both content and functionality. We launched two additional exciting themes
for iHumanpedia, “Earth Treasure Hunt” and “Animal Architects,” which were specifically
designed to nurture the scientific curiosity of children. As we continue to expand our content library, we are constantly developing innovative
ways to engage users and enrich their experiences. For example, we hosted popular science competitions that encouraged participants to
create science-themed short-form videos, among which the most outstanding entries would be featured on the iHumanpedia app. These
initiatives as well as others we have rolled out all received enthusiastic feedback from users and are encouraging more active participation
and contributing to a more vibrant community.”
“Internationally,
we enhanced the appeal of our products by rolling out popular seasonal themes that resonate with overseas users. For example, we launched
a Halloween pack for Aha World which offered a wide selection of classic Halloween costumes and immersive, spooky experiences
that were highly popular among younger audiences. Aha World has recently surged to rank among the top three most popular children’s
apps on Apple’s app store in the U.S. These ongoing efforts to drive product excellence are increasingly earning us international
recognition. Notably, we were awarded the prestigious w3 Gold Award in the Mobile Apps & Sites - Family & Kids category,
for bekids Reading. With thousands of entries from across the globe annually, the w3 Awards is one of the most prestigious honors
in digital design, marketing, media and technology that recognizes the industry’s best across user experiences, content, and creativity.
Winning the w3 Gold Award represents a substantial recognition of the high quality and innovative nature of our products and marks another
significant milestone for us as a company specialized in child intellectual development.”
1
“Adjusted operating income” and “adjusted net income” exclude share-based compensation expenses.
Please see “Non-GAAP Financial Measures” and “Unaudited Reconciliation of GAAP and non-GAAP Results” at the end
of this press release.
2
“Average total MAUs” refers to the monthly average of the sum of the MAUs of each of the Company’s apps
during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once
in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.
“Our
smart devices business also continued to make solid progress with the launch of the second generation of Logic Pal, an easy-to-operate
device designed to facilitate early childhood word recognition, pronunciation, and cognitive growth through pluggable cards and interactive
activities. To diversify our offerings, we have also launched Diandian Storyteller, a portable device that empowers children to
enhance their storytelling abilities and expand their imagination.”
“We are truly encouraged by the momentum
across our entire portfolio and take great pride in our team’s resolve and consistent execution. I am excited about the opportunities
that lie ahead and the potential for our continuous growth and innovation,” concluded Dr. Dai.
Ms. Vivien Weiwei Wang, Director and Chief
Financial Officer of iHuman, added, “With an unwavering focus on long-term growth, we continue to invest in refining our product
lineup while steadily expanding our overseas presence. Our dedication and relentless efforts to the business have enabled us to achieve
another solid quarter. We once again recorded revenue growth on both an annual and sequential basis, marking our seventh consecutive profitable
quarter. This remarkable achievement has further solidified our financial position, establishing a solid foundation for our future expansion.”
“While
we continue to advance our strategic priorities, we are also actively engaged in public initiatives that aim to inspire young minds and
support their holistic development. Since the launch of bekids Coding, we have been enthusiastic participants in the Hour
of Code, a global initiative that introduces tens of millions of students worldwide to computer science and programming through free coding
tutorials and activities. In 2022, several elementary schools across the United States completed our Hour of Code challenge and shared
their experiences on social media. This year, we are thrilled to participate in the Hour of Code initiative again, aiming to further inspire
and engage children worldwide. Our participation in such events has strengthened our brand profile and influence internationally. As we
move forward, our commitment to managing a strong portfolio of products and driving business growth will remain central to our strategy,
ensuring sustainable development and creating more value for our shareholders.”
Third Quarter 2023 Unaudited Financial Results
Revenues
Revenues
were RMB261.5 million (US$35.8 million), an increase of 4.0% from RMB251.5 million in the same period last year, primarily driven
by user expansion and enhanced user engagement.
Average
total MAUs for the quarter were 25.36 million, an increase of 22.9% year-over-year from 20.63 million in the same period last year.
The number of paying users3 was 1.54 million.
Cost of Revenues
Cost
of revenues was RMB74.9 million (US$10.3 million), maintaining approximately the same level of RMB74.4 million in the same period
last year.
Gross Profit and Gross Margin
Gross
profit was RMB186.6 million (US$25.6 million), an increase of 5.4% from RMB177.1 million in the same period last year. Gross margin
was 71.4%, compared with 70.4% in the same period last year.
Operating Expenses
Total operating expenses were RMB146.2 million
(US$20.0 million), an increase of 5.5% from RMB138.6 million in the same period last year.
3
“Paying users” refers to users who paid subscription fees for premium content on any of the Company’s
apps during a specific period; a user who makes payments across different apps using the same registered account is counted as one paying
user, and a user who makes payments for the same app multiple times in the same period is counted as one paying user.
Research
and development expenses were RMB66.2 million (US$9.1 million), a decrease of 7.9% from RMB71.9 million in the same period last
year, primarily due to payroll-related cost savings and decreased outsourcing expenses as a result of the continued optimization of our
operational efficiency.
Sales
and marketing expenses were RMB54.0 million (US$7.4 million), an increase of 29.6% from RMB41.7 million in the same period last
year, primarily due to increased strategic spending on promotional activities.
General
and administrative expenses were RMB26.1 million (US$3.6 million), compared with RMB25.0 million in the same period last year.
Operating
Income
Operating
income was RMB40.4 million (US$5.5 million), compared with RMB38.5 million in the same period last year.
Excluding
share-based compensation expenses, adjusted operating income was RMB42.9 million (US$5.9 million), compared with RMB42.5 million
in the same period last year.
Net Income
Net
income was RMB51.9 million (US$7.1 million), an increase of 31.5% from RMB39.5 million in the same period last year.
Adjusted net income was RMB54.4 million (US$7.5
million), an increase of 25.1% from RMB43.5 million in the same period last year.
Basic
and diluted net income per ADS were RMB0.98 (US$0.13) and RMB0.95 (US$0.13), respectively, compared with RMB0.74 and RMB0.73 in
the same period last year. Each ADS represents five Class A ordinary shares of the Company.
Adjusted
diluted net income per ADS was RMB0.99 (US$0.14), compared with RMB0.80 in the same period last year.
Deferred
Revenue and Customer Advances
Deferred revenue and customer advances were RMB320.4
million (US$43.9 million) as of September 30, 2023, compared with RMB379.1 million as of December 31, 2022.
Cash, Cash Equivalents and Time Deposits
Cash,
cash equivalents and time deposits were RMB1,174.2 million (US$160.9 million) as of September 30, 2023, compared with RMB1,050.0
million as of December 31, 2022.
Extension of Share Repurchase Program
Given its confidence in the Company's business prospects, the board
of directors (the “Board”) has authorized another extension of the Company’s existing share repurchase program, as authorized
in December 2021 and extended in December 2022, by twelve months through December 31, 2024. Pursuant to the extended share
repurchase program, the Company’s proposed repurchases may be made from time to time through open market transactions at prevailing
market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the
market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions
will be subject to the Securities and Exchange Commission Rule 10b-18 and Rule 10b5-1 requirements. The Board will continue
to review the extended share repurchase program periodically, and may authorize adjustments to its terms and size. The Company expects
to continue to fund the repurchases under the extended share repurchase program with its existing cash balance.
Exchange Rate Information
The U.S. dollar (US$) amounts disclosed in this
press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience
of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical
release of the Board of Governors of the Federal Reserve System as of September 29, 2023, which was RMB7.2960 to US$1.00. The percentages
stated in this press release are calculated based on the RMB amounts.
Non-GAAP Financial Measures
iHuman
considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income
per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation
of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared
and presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income
and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income
and adjusted diluted net income per ADS enable iHuman’s management to assess its operating results without considering the impact
of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful
information to investors in understanding and evaluating the Company’s current operating performance and prospects in the same manner
as management does, if they so choose.
Non-GAAP financial measures are not defined under
U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which
possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue
to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP
financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore
their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation
from or as a substitute for the financial information prepared and presented in accordance with GAAP.
Safe Harbor Statement
This announcement contains forward-looking statements.
These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act
of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,”
“future,” “intends,” “plans,” “believes,” “estimates” and similar statements.
Statements that are not historical facts, including statements about iHuman’s beliefs and expectations, are forward-looking statements.
Among other things, the description of the management’s quotations in this announcement contains forward-looking statements. iHuman
may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”),
in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors
or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual
results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman’s
growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract
and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the
market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations
regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions
underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman’s filings
with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any
obligation to update any forward-looking statement, except as required under applicable law.
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered,
intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming
intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in
the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities
with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman’s
unique, fun and interactive product offerings stimulate children’s natural curiosity and exploration. The Company’s comprehensive
suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety
of areas to develop children’s abilities in speaking, critical thinking, independent reading and creativity, and foster their natural
interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and
big data analysis on children’s behavior & psychology, iHuman believes it will continue to provide superior experience
that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated
suite of tech-powered, intellectual development products.
For more information about iHuman, please visit
https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin
Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In China
Ms. Alice Li
Phone: +86-13381389369
E-mail: alice.li@christensencomms.com
In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands of Renminbi (“RMB”)
and U.S. dollars (“US$”)
except
for number of shares, ADSs, per share and per ADS data)
| | |
December 31, | | |
September 30, | | |
September 30, | |
| | |
2022 | | |
2023 | | |
2023 | |
| | |
RMB | | |
RMB | | |
US$ | |
| ASSETS | |
| | | |
| | | |
| | |
| Current assets | |
| | | |
| | | |
| | |
| Cash and cash equivalents | |
| 1,049,999 | | |
| 1,037,751 | | |
| 142,236 | |
| Time deposits | |
| - | | |
| 136,416 | | |
| 18,697 | |
| Accounts receivable, net | |
| 79,614 | | |
| 69,381 | | |
| 9,509 | |
| Inventories, net | |
| 19,127 | | |
| 13,457 | | |
| 1,844 | |
| Amounts due from related parties | |
| 2,286 | | |
| 1,979 | | |
| 271 | |
| Prepayments and other current assets | |
| 102,765 | | |
| 83,999 | | |
| 11,513 | |
| Total current assets | |
| 1,253,791 | | |
| 1,342,983 | | |
| 184,070 | |
| Non-current assets | |
| | | |
| | | |
| | |
| Property and equipment, net | |
| 9,205 | | |
| 6,530 | | |
| 895 | |
| Intangible assets, net | |
| 24,872 | | |
| 24,093 | | |
| 3,302 | |
| Operating lease right-of-use assets | |
| 12,782 | | |
| 4,056 | | |
| 556 | |
| Long-term investment | |
| 26,333 | | |
| 26,333 | | |
| 3,609 | |
| Other non-current assets | |
| 6,416 | | |
| 7,843 | | |
| 1,076 | |
| Total non-current assets | |
| 79,608 | | |
| 68,855 | | |
| 9,438 | |
| Total assets | |
| 1,333,399 | | |
| 1,411,838 | | |
| 193,508 | |
| | |
| | | |
| | | |
| | |
| LIABILITIES | |
| | | |
| | | |
| | |
| Current liabilities | |
| | | |
| | | |
| | |
| Accounts payable | |
| 24,206 | | |
| 16,235 | | |
| 2,225 | |
| Deferred revenue and customer advances | |
| 379,063 | | |
| 320,438 | | |
| 43,920 | |
| Amounts due to related parties | |
| 6,944 | | |
| 10,917 | | |
| 1,496 | |
| Accrued expenses and other current liabilities | |
| 144,717 | | |
| 131,722 | | |
| 18,054 | |
| Current operating lease liabilities | |
| 6,123 | | |
| 1,818 | | |
| 249 | |
| Total current liabilities | |
| 561,053 | | |
| 481,130 | | |
| 65,944 | |
| Non-current liabilities | |
| | | |
| | | |
| | |
| Non-current operating lease liabilities | |
| 2,894 | | |
| 2,361 | | |
| 324 | |
| Total non-current liabilities | |
| 2,894 | | |
| 2,361 | | |
| 324 | |
| Total liabilities | |
| 563,947 | | |
| 483,491 | | |
| 66,268 | |
| SHAREHOLDERS’ EQUITY | |
| | | |
| | | |
| | |
| Ordinary shares (par value of US$0.0001 per share, 700,000,000 Class A shares authorized as of December 31, 2022 and September 30, 2023; 125,122,382 Class A shares issued and 121,722,467 outstanding as of December 31, 2022; 125,122,382 Class A shares issued and 119,698,967 outstanding as of September 30, 2023; 200,000,000 Class B shares authorized, 144,000,000 Class B ordinary shares issued and outstanding as of December 31, 2022 and September 30, 2023; 100,000,000 shares (undesignated) authorized, nil shares (undesignated) issued and outstanding as of December 31, 2022 and September 30, 2023) | |
| 185 | | |
| 185 | | |
| 25 | |
| Additional paid-in capital | |
| 1,079,099 | | |
| 1,086,502 | | |
| 148,917 | |
| Treasury stock | |
| (7,123 | ) | |
| (16,665 | ) | |
| (2,284 | ) |
| Statutory reserves | |
| 7,967 | | |
| 7,967 | | |
| 1,092 | |
| Accumulated other comprehensive income | |
| 10,497 | | |
| 23,895 | | |
| 3,275 | |
| Accumulated deficit | |
| (321,173 | ) | |
| (173,537 | ) | |
| (23,785 | ) |
| Total shareholders’ equity | |
| 769,452 | | |
| 928,347 | | |
| 127,240 | |
| Total liabilities and shareholders’ equity | |
| 1,333,399 | | |
| 1,411,838 | | |
| 193,508 | |
iHuman Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS
(Amounts in thousands of Renminbi (“RMB”)
and U.S. dollars (“US$”)
except for number of shares, ADSs, per share
and per ADS data)
| | |
For
the three months ended | | |
For
the nine months ended | |
| | |
September 30, | | |
June 30, | | |
September 30, | | |
September 30, | | |
September 30, | | |
September 30, | | |
September 30, | |
| | |
2022 | | |
2023 | | |
2023 | | |
2023 | | |
2022 | | |
2023 | | |
2023 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | | |
RMB | | |
RMB | | |
US$ | |
| Revenues | |
| 251,527 | | |
| 240,993 | | |
| 261,496 | | |
| 35,841 | | |
| 724,813 | | |
| 767,692 | | |
| 105,221 | |
| Cost of revenues | |
| (74,422 | ) | |
| (70,160 | ) | |
| (74,871 | ) | |
| (10,262 | ) | |
| (214,636 | ) | |
| (224,667 | ) | |
| (30,793 | ) |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Gross
profit | |
| 177,105 | | |
| 170,833 | | |
| 186,625 | | |
| 25,579 | | |
| 510,177 | | |
| 543,025 | | |
| 74,428 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Operating expenses | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Research and development expenses | |
| (71,859 | ) | |
| (63,412 | ) | |
| (66,168 | ) | |
| (9,069 | ) | |
| (246,685 | ) | |
| (191,253 | ) | |
| (26,213 | ) |
| Sales and marketing expenses | |
| (41,669 | ) | |
| (40,564 | ) | |
| (53,994 | ) | |
| (7,400 | ) | |
| (111,105 | ) | |
| (134,993 | ) | |
| (18,502 | ) |
| General
and administrative expenses | |
| (25,035 | ) | |
| (25,982 | ) | |
| (26,070 | ) | |
| (3,573 | ) | |
| (79,942 | ) | |
| (78,787 | ) | |
| (10,799 | ) |
| Total
operating expenses | |
| (138,563 | ) | |
| (129,958 | ) | |
| (146,232 | ) | |
| (20,042 | ) | |
| (437,732 | ) | |
| (405,033 | ) | |
| (55,514 | ) |
| Operating
income | |
| 38,542 | | |
| 40,875 | | |
| 40,393 | | |
| 5,537 | | |
| 72,445 | | |
| 137,992 | | |
| 18,914 | |
| Other income,
net | |
| 9,611 | | |
| 8,132 | | |
| 19,507 | | |
| 2,674 | | |
| 15,875 | | |
| 33,721 | | |
| 4,622 | |
| Income before income taxes | |
| 48,153 | | |
| 49,007 | | |
| 59,900 | | |
| 8,211 | | |
| 88,320 | | |
| 171,713 | | |
| 23,536 | |
| Income tax
expenses | |
| (8,675 | ) | |
| (6,933 | ) | |
| (7,984 | ) | |
| (1,094 | ) | |
| (13,934 | ) | |
| (24,077 | ) | |
| (3,300 | ) |
| Net
income | |
| 39,478 | | |
| 42,074 | | |
| 51,916 | | |
| 7,117 | | |
| 74,386 | | |
| 147,636 | | |
| 20,236 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Net income per ADS: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| - Basic | |
| 0.74 | | |
| 0.80 | | |
| 0.98 | | |
| 0.13 | | |
| 1.39 | | |
| 2.79 | | |
| 0.38 | |
| - Diluted | |
| 0.73 | | |
| 0.77 | | |
| 0.95 | | |
| 0.13 | | |
| 1.38 | | |
| 2.70 | | |
| 0.37 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Weighted average number of ADSs: | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| - Basic | |
| 53,240,710 | | |
| 52,804,594 | | |
| 52,747,426 | | |
| 52,747,426 | | |
| 53,341,120 | | |
| 52,834,352 | | |
| 52,834,352 | |
| - Diluted | |
| 54,114,651 | | |
| 54,725,528 | | |
| 54,772,536 | | |
| 54,772,536 | | |
| 54,043,728 | | |
| 54,753,124 | | |
| 54,753,124 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Total share-based compensation expenses included in: | | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Cost of revenues | |
| 77 | | |
| 70 | | |
| 67 | | |
| 9 | | |
| 180 | | |
| 235 | | |
| 32 | |
| Research and development expenses | |
| 2,045 | | |
| 1,142 | | |
| 1,160 | | |
| 159 | | |
| 3,813 | | |
| 2,940 | | |
| 403 | |
| Sales and marketing expenses | |
| 698 | | |
| 59 | | |
| 147 | | |
| 20 | | |
| 1,040 | | |
| 585 | | |
| 80 | |
| General and administrative expenses | |
| 1,187 | | |
| 1,160 | | |
| 1,105 | | |
| 151 | | |
| 2,963 | | |
| 3,557 | | |
| 488 | |
iHuman Inc.
UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP
RESULTS
(Amounts in thousands of Renminbi (“RMB”)
and U.S. dollars (“US$”)
except for number of shares, ADSs, per share
and per ADS data)
| | |
For
the three months ended | | |
For
the nine months ended | |
| | |
September 30, | | |
June 30, | | |
September 30, | | |
September 30, | | |
September 30, | | |
September 30, | | |
September 30, | |
| | |
2022 | | |
2023 | | |
2023 | | |
2023 | | |
2022 | | |
2023 | | |
2023 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | | |
RMB | | |
RMB | | |
US$ | |
| Operating income | |
| 38,542 | | |
| 40,875 | | |
| 40,393 | | |
| 5,537 | | |
| 72,445 | | |
| 137,992 | | |
| 18,914 | |
| Share-based
compensation expenses | |
| 4,007 | | |
| 2,431 | | |
| 2,479 | | |
| 339 | | |
| 7,996 | | |
| 7,317 | | |
| 1,003 | |
| Adjusted
operating income | |
| 42,549 | | |
| 43,306 | | |
| 42,872 | | |
| 5,876 | | |
| 80,441 | | |
| 145,309 | | |
| 19,917 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Net income | |
| 39,478 | | |
| 42,074 | | |
| 51,916 | | |
| 7,117 | | |
| 74,386 | | |
| 147,636 | | |
| 20,236 | |
| Share-based
compensation expenses | |
| 4,007 | | |
| 2,431 | | |
| 2,479 | | |
| 339 | | |
| 7,996 | | |
| 7,317 | | |
| 1,003 | |
| Adjusted
net income | |
| 43,485 | | |
| 44,505 | | |
| 54,395 | | |
| 7,456 | | |
| 82,382 | | |
| 154,953 | | |
| 21,239 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Diluted net income per ADS | |
| 0.73 | | |
| 0.77 | | |
| 0.95 | | |
| 0.13 | | |
| 1.38 | | |
| 2.70 | | |
| 0.37 | |
| Impact of
non-GAAP adjustments | |
| 0.07 | | |
| 0.04 | | |
| 0.04 | | |
| 0.01 | | |
| 0.14 | | |
| 0.13 | | |
| 0.02 | |
| Adjusted
diluted net income per ADS | |
| 0.80 | | |
| 0.81 | | |
| 0.99 | | |
| 0.14 | | |
| 1.52 | | |
| 2.83 | | |
| 0.39 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Weighted average number of
ADSs – diluted | |
| 54,114,651 | | |
| 54,725,528 | | |
| 54,772,536 | | |
| 54,772,536 | | |
| 54,043,728 | | |
| 54,753,124 | | |
| 54,753,124 | |
| Weighted average number
of ADSs – adjusted | |
| 54,114,651 | | |
| 54,725,528 | | |
| 54,772,536 | | |
| 54,772,536 | | |
| 54,043,728 | | |
| 54,753,124 | | |
| 54,753,124 | |
iHuman (NYSE:IH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
iHuman (NYSE:IH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
